89980-92-7 Usage
Description
1,4-Benzenedimethanol, 2-bromois a chemical compound characterized by the molecular formula C8H10Br2O2. It is a white to off-white solid that exhibits solubility in both water and organic solvents. This versatile building block is utilized in the synthesis of a range of organic compounds, including polymers, resins, and pharmaceuticals. Due to its potential hazards, it is crucial to handle 1,4-Benzenedimethanol, 2-bromowith care and adhere to proper safety protocols.
Uses
Used in Pharmaceutical Industry:
1,4-Benzenedimethanol, 2-bromoserves as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties, contributing to advancements in medicinal chemistry.
Used in Polymer Production:
In the polymer industry, 1,4-Benzenedimethanol, 2-bromoacts as a vital building block for the creation of diverse polymers. These polymers can be tailored for specific applications, such as in plastics, coatings, and adhesives, due to the compound's reactive functional groups.
Used in Resin Manufacturing:
1,4-Benzenedimethanol, 2-bromois also employed in the production of resins, where its chemical properties enable the formulation of resins with tailored characteristics for use in various industrial applications, including coatings, composites, and adhesives.
Overall, 1,4-Benzenedimethanol, 2-bromois a multifaceted chemical with applications across different industries, primarily due to its role as a synthetic building block and its solubility in various solvents.
Check Digit Verification of cas no
The CAS Registry Mumber 89980-92-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,8 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 89980-92:
(7*8)+(6*9)+(5*9)+(4*8)+(3*0)+(2*9)+(1*2)=207
207 % 10 = 7
So 89980-92-7 is a valid CAS Registry Number.
89980-92-7Relevant articles and documents
QUINAZOLINE DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS
-
Paragraph 0204, (2020/07/15)
The present disclosure provides certain quinazoline compounds that inhibit ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) enzymatic activity and are therefore useful for the treatment of diseases and conditions modulated at least in part by ENPP1. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING SAME
-
Paragraph 00153-00155; 001083-001085, (2019/06/05)
Provided herein are compounds and methods for modulating abnormal repeat expansions of gene sequences. More particularly, provided are inhibitors of RNA and the uses of such inhibitors in regulating nucleotide repeat expansions, e.g., to treat Myotonic Dystrophy Type 1 (DM1 ), Myotonic Dystrophy Type 2 (DM2), Fuchs dystrophy, Huntington Disease, Amyotrophic Lateral Sclerosis, or Frontotemporal Dementia.
C,O-SPIRO ARYL GLYCOSIDE COMPOUNDS, PREPARATION THEREFOR AND USE THEREOF
-
Paragraph 0098, (2018/05/16)
The present invention provides C, O-spiro aryl glycoside compounds, preparation therefor and use thereof. Specifically provided are the compounds represented by the formula (I), wherein the definitions of each group are described in the specification. The
